The Biomet Magnum hip replacement device is a metal on metal system which includes chromium and cobalt in its composition. The friction caused by the metal components rubbing against one another can result is metal fragment being released into the surrounding tissue and blood stream. These metal fragments can lead to tissue damage including inflammation, bone loss, necrosis, and blood poisoning known as metallosis. Other possible side effects from hip implants include loosening, dislocation and possible fracture.
Between 2000 and 2011, the FDA has reported nearly 17,000 negative events associated with metal on metal hips. These reports lead to an FDA order requiring manufacturers of metal on metal hips implants devices to collect and report data on any and all adverse health effects associated with these devices. On June 27 and 28, 2012, the FDA convened a panel of experts to discuss the safety and to recommend the best practices for monitoring patients with metal on metal hips. During this conference the AP reported Government health experts as stating “there are few reasons to continue using metal-on-metal hip implants, amid growing evidence that the devices can break down early and expose patients to dangerous metallic particles.”
In the case of Biomet Metal on Metal hips, plaintiffs are alleging a high early failure rate that requires a revision surgery. HarrisMartin Publishing reported on June 28, 2012 that a motion was requested by counsel for plaintiffs seeking to establish a Multidistrict Litigation in ether New York or California for Biomet Metal on Metal Hips.
If you or a loved one has experienced injuries resulting from Biomet Metal on Metal Hip Implant, please contact Pogust Braslow & Millrood for a free consultation to make sure that you rights are protected.